Efficacy and Safety of Combination Therapy Consisting of Angiotensin II Type 1 Receptor Blocker, Calcium Channel Blocker and Hydrochlorothiazide in Patients With Hypertension

BACKGROUND: Many patients continue to have high blood pressure (BP) even after treatment with high-dose (H)-angiotensin II type 1 receptor blocker (ARB)/calcium channel blocker (CCB) or middle-dose (M)-ARB/CCB/hydrochlorothiazide (HCTZ). METHODS: Thirty-two hypertensive patients who had the use of H...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiga, Yuhei, Miura, Shin-ichiro, Motozato, Kota, Yoshimine, Yuka, Norimatsu, Kenji, Arimura, Tadaaki, Koyoshi, Rie, Morii, Joji, Kuwano, Takashi, Inoue, Ken, Shirotani, Tetsuro, Fujisawa, Kazuaki, Matsunaga, Eiyu, Saku, Keijiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215013/
https://www.ncbi.nlm.nih.gov/pubmed/28090225
http://dx.doi.org/10.14740/jocmr2838w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215013/
https://www.ncbi.nlm.nih.gov/pubmed/28090225
http://dx.doi.org/10.14740/jocmr2838w

Ejemplares similares